基于关键地区、市场参与者、规模和份额的 2 型糖尿病治疗市场控制不力 - 到 2031 年的预测

  • Report Code : TIPRE00016882
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Inadequately Controlled Type-II Diabetes Treatment Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

市场介绍 糖尿病是一种可以完全影响身体的严重疾病。糖尿病的发生是由于胰腺内胰岛素分泌不良所致。胰腺分泌胰岛素是一种由β细胞产生的激素,负责将食物中的葡萄糖转化为能量。糖尿病有不同的类型,各类糖尿病的身体状况严重而复杂。 2 型是一种长期的身体状况,胰腺无法产生足够的胰岛素来将食物能量转化为葡萄糖。 2 型糖尿病主要与遗传和家庭相关危险因素有关。一般来说,2型糖尿病发生在45岁以后的成年人中,但如今,儿童和年轻人的糖尿病患病率正在增加。 2 型糖尿病的一些主要症状是过度口渴、感到疲倦和昏昏欲睡、总是感到饥饿、需要更多时间来治愈等。糖尿病是一种无法治愈的疾病,只能通过改变生活方式和药物治疗来控制。药物通过药丸或注射来增加人体内的胰岛素水平。使用注射器和胰岛素笔注射胰岛素。 市场动态 控制不力的 II 型糖尿病治疗市场在预测期内呈现出显着的演变。全球糖尿病患病率的上升是推动 2 型糖尿病治疗市场控制不力的主要因素。根据国际糖尿病联盟 (IDF) 第 7 版的数据,全球有 4.15 亿人患有糖尿病。老年人口的增加和人们生活方式的改变也是全球糖尿病患病率迅速上升的原因。非政府组织越来越多地采取行动来治疗人们的糖尿病,这将促进该市场的增长。技术进步导致高度改进的糖尿病治疗药物的开发,将推动控制不充分的 2 型糖尿病治疗市场的增长。然而,不利的报销政策将限制控制不力的2型糖尿病治疗市场的发展。此外,高成本药物和技术错误的可能性将影响控制不充分的 2 型糖尿病治疗市场的增长。 市场范围 《到2031年控制不充分的II型糖尿病治疗市场分析》是对医疗保健行业药品的专业深入研究,特别关注全球市场趋势分析。本报告概述了控制不力的 II 型糖尿病治疗市场,并按药物类别、设备和最终用户进行了详细的市场细分。控制不力的二型糖尿病治疗市场预计在预测期内将出现高速增长。它重点关注控制不充分的 II 型糖尿病治疗市场中主要参与者的市场状况的重要统计数据,并提供市场的关键机会和趋势。 市场细分 市场根据药物类别、设备和最终用户进行分类。根据药物类别,市场分为胰岛素和非胰岛素。根据设备,市场细分为胰岛素泵、胰岛素笔、血糖仪等。根据最终用户,市场细分为医院、门诊手术中心、诊所等。

Inadequately Controlled Type-II Diabetes Treatment Market: Strategic Insights

Inadequately Controlled Type-II Diabetes Treatment Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Bayer AG
  • Abbott
  • Boehringer Ingelheim
  • Johnson Johnson Services Inc
  • Merck KGaA
  • Pfizer Inc
  • ASTRAZENECA
  • F Hoffmann La Roche Ltd
  • Sanofi

Regional Overview

Regional And Country Scope
  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

Market Segmentation

Segment 1药物类别
  • 胰岛素
  • 非胰岛素
Segment2设备
  • 胰岛素泵
  • 胰岛素笔
  • 血糖仪等
Segment3最终用户
  • 医院
  • 门诊手术中心
  • 诊所等
Segment4地理
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
该报告详细阐述了该行业的概况,包括定性和定量信息。它根据各个细分市场对控制不充分的 II 型糖尿病治疗市场进行了概述和预测。该报告还包括 2021 年至 2031 年五个主要区域的市场规模和预测估计,即:北美、亚太地区 (APAC)、欧洲、中东和非洲 (MEA) 以及南美洲和中美洲 (SCAM)。每个地区控制不力的二型糖尿病治疗市场随后被细分为各自的国家和细分市场。它提供了对全球 18 个国家以及该地区的最新趋势和机遇的分析和预测。报告从需求和供给两个方面分析了影响II型糖尿病治疗市场控制不力的因素。此外,它还评估预测期内影响市场的市场动态,即驱动因素、限制因素、机会和未来趋势。它还包括对所有五个区域的精确 PEST 分析,即:北美、亚太地区、欧洲、中东和非洲以及南美洲和中美洲,在评估了影响这些地区 II 型糖尿病治疗市场控制不力的政治、社会、经济和技术因素后。 市场参与者 该报告包含了控制不充分的 II 型糖尿病治疗市场作为无机和有机增长策略的关键进展。许多公司正在转向有机增长战略,如产品批准、产品发布以及其他活动和专利等。市场上注意到的无机增长策略是收购、合作和伙伴关系。这些活动为市场参与者扩大业务和客户群铺平了道路。随着全球市场对控制不充分的 II 型糖尿病治疗的需求不断增加,预计控制不充分的 II 型糖尿病治疗市场的市场参与者将在未来几年获得盈利增长机会。以下是几家涉足控制不力的二型糖尿病治疗市场的公司名单。该报告还提供了控制不充分的 II 型糖尿病治疗市场中主要参与者的概况,以及他们的 SWOT 分析和市场策略。此外,该报告还重点关注领先的市场参与者,提供公司简介、过去三年的财务信息、提供的组件和服务以及过去五年的关键发展信息。
    • 拜耳公司 • 雅培 • 勃林格殷格翰 • 强生服务公司 • 默克公司 • 辉瑞公司 • 阿斯利康 • F.霍夫曼-拉罗氏有限公司 • 赛诺菲 • 百时美施贵宝
Insight 合作伙伴的专业研究和分析团队由经验丰富的专业人员组成,具有先进的统计专业知识,并在当前研究中提供各种定制选项。

Inadequately Controlled Type-II Diabetes Treatment Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 药物类别
  • 胰岛素
  • 非胰岛素
By 设备
  • 胰岛素泵
  • 胰岛素笔
  • 血糖仪等
By 最终用户
  • 医院
  • 门诊手术中心
  • 诊所等
By 地理
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太地区其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Bayer AG
  • Abbott
  • Boehringer Ingelheim
  • Johnson Johnson Services Inc
  • Merck KGaA
  • Pfizer Inc
  • ASTRAZENECA
  • F Hoffmann La Roche Ltd
  • Sanofi
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Bayer AG
    2. Abbott
    3. Boehringer Ingelheim
    4. Johnson & Johnson Services, Inc.
    5. Merck KGaA
    6. Pfizer Inc.
    7. ASTRAZENECA
    8. F. Hoffmann-La Roche Ltd
    9. Sanofi
    10. Bristol-Myers Squibb

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..